Disclosure 0001470831-26-000883-2

SEC FORM 4

$320,052.86

Bicara Therapeutics Inc. (BCAX)

Sale of 14,058 shares at $22.7666 per share.

Reporting Person Cohlhepp Ryan · Officer Title President, COO & Interim CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001470831-26-000883 · filed 2026-09-10 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Bicara Therapeutics Inc. (BCAX)." Disclosed 2026-09-10. https://desqlong.com/cards/0001470831-26-000883-2 (retrieved 2026-09-26).